| United States Board of Patent Appeals Denies Siemens Healthcare Diagnostics' Request for Rehearing on Enzo's Pending Universal Interference Patent (Business Wire) NEW YORK----Enzo Biochem, Inc., today reported that the Board of Patent Appeals and Interferences of the United States Patent and Trademark Office has issued a Decision denying a Request for Rehearing filed by Siemens Healthcare Diagnostics in a patent interference proceeding relating to Enzo Life Science’s application for nucleic acid signal amplification and Siemens U.S. us.rd.yahoo.com |
FDA Questions Avastin's Use in Breast Cancer The FDA questioned the benefit of using Roche's top-selling cancer drug for breast cancer, ahead of an advisory review of Avastin set for Tuesday. online.wsj.com |
Stereotaxis, Inc. Q2 2010 Earnings Call Transcript Stereotaxis, Inc. (STXS)Q2 2010 Earnings Call TranscriptAugust 2, 2010 4:30 pm ETComplete Story » seekingalpha.com |
Private Biotechs Take Different Avenues to Rake in Cash The Burrill Report submits: By Marie DaghlianReata Pharmaceuticals is filling its coffers ahead of late stage trials with a lucrative deal for its mid-stage treatment for chronic kidney disease. The private Irving, Texas-based biopharma is granting Abbott Laboratories (ABT) exclusive rights to develop and commercialize bardoxolone outside the United States, excluding certain Asian markets. In return, Reata will receive $450 million in upfront and near-term payments, and a minority equity investment in the company. Complete Story » seekingalpha.com |
Elmo Protects Families from the Flu - Video HHS Secretary Kathleen Sebelius, Sesame Street and the Ad Council Launch National PSA to Protect Families from the Flu feedproxy.google.com |